» Articles » PMID: 22728937

Spirochete Antigens Persist Near Cartilage After Murine Lyme Borreliosis Therapy

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2012 Jun 26
PMID 22728937
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

An enigmatic feature of Lyme disease is the slow resolution of musculoskeletal symptoms that can continue after treatment, with some patients developing an inflammatory arthritis that becomes refractory to antibiotic therapy. Using intravital microscopy and the mouse model of Lyme borreliosis, we observed that Borrelia burgdorferi antigens, but not infectious spirochetes, can remain adjacent to cartilage for extended periods after antibiotic treatment. B. burgdorferi was not recovered by culture or xenodiagnosis with ticks after antibiotic treatment of WT mice and all but one of the immunodeficient mice with heightened pathogen burden due to impaired TLR responsiveness. Amorphous GFP+ deposits were visualized by intravital microscopy in the entheses of antibiotic-treated mice infected with GFP-expressing spirochetes and on the ear cartilage surface in sites where immunofluorescence staining detected spirochete antigens. Naive mice were not infected by tissue transplants from antibiotic-treated mice even though transplants contained spirochete DNA. Tissue homogenates from antibiotic-treated mice induced IgG reactive with B. burgdorferi antigens after immunization of naive mice and stimulated TNF-α production from macrophages in vitro. This is the first direct demonstration that inflammatory B. burgdorferi components can persist near cartilaginous tissue after treatment for Lyme disease. We propose that these deposits could contribute to the development of antibiotic-refractory Lyme arthritis.

Citing Articles

Unguarded liabilities: complex amino acid dependence exposes unique avenues of inhibition.

Holly K, Kataria A, Flaherty D, Groshong A Front Antibiot. 2025; 3():1395425.

PMID: 39816271 PMC: 11732028. DOI: 10.3389/frabi.2024.1395425.


Development and utilization of expressing green fluorescent protein to study spirochete-host interactions and antibody-mediated clearance: expanding the toolbox for syphilis research.

Delgado K, Vicente C, Hennelly C, Aghakhanian F, Parr J, Claffey K mBio. 2024; 16(1):e0325324.

PMID: 39611839 PMC: 11708019. DOI: 10.1128/mbio.03253-24.


Role of Dual Specificity Phosphatase 1 (DUSP1) in influencing inflammatory pathways in macrophages modulated by lipoproteins.

Kumaresan V, Hung C, Hermann B, Seshu J bioRxiv. 2024; .

PMID: 39605372 PMC: 11601599. DOI: 10.1101/2024.11.20.624562.


Development and utilization of expressing green fluorescent protein to study spirochete-host interactions and antibody-mediated clearance: expanding the toolbox for syphilis research.

Delgado K, Vicente C, Hennelly C, Aghakhanian F, Parr J, Claffey K bioRxiv. 2024; .

PMID: 39484466 PMC: 11526989. DOI: 10.1101/2024.10.21.619476.


What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome.

Wester K, Nwokeabia B, Hassan R, Dunphy T, Osondu M, Wonders C Cureus. 2024; 16(7):e64987.

PMID: 39161484 PMC: 11332314. DOI: 10.7759/cureus.64987.


References
1.
Steere A, Schoen R, Taylor E . The clinical evolution of Lyme arthritis. Ann Intern Med. 1987; 107(5):725-31. DOI: 10.7326/0003-4819-107-5-725. View

2.
Krupp L, Hyman L, Grimson R, Coyle P, Melville P, Ahnn S . Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003; 60(12):1923-30. DOI: 10.1212/01.wnl.0000071227.23769.9e. View

3.
Young G, Turner S, Davies J, Sundqvist G, Figdor D . Bacterial DNA persists for extended periods after cell death. J Endod. 2007; 33(12):1417-20. DOI: 10.1016/j.joen.2007.09.002. View

4.
Wormser G, Schwartz I . Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev. 2009; 22(3):387-95. PMC: 2708393. DOI: 10.1128/CMR.00004-09. View

5.
Barthold S, Sidman C, Smith A . Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg. 1992; 47(5):605-13. DOI: 10.4269/ajtmh.1992.47.605. View